3fra
From Proteopedia
(Difference between revisions)
m (Protected "3fra" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3fra.png|left|200px]] | [[Image:3fra.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3fra", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3fra| PDB=3fra | SCENE= }} | {{STRUCTURE_3fra| PDB=3fra | SCENE= }} | ||
===Staphylococcus aureus F98Y DHFR complexed with iclaprim=== | ===Staphylococcus aureus F98Y DHFR complexed with iclaprim=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_19211577}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 19211577 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_19211577}} | {{ABSTRACT_PUBMED_19211577}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Dihydrofolate reductase]] | + | *[[Dihydrofolate reductase|Dihydrofolate reductase]] |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:019211577</ref><references group="xtra"/> |
[[Category: Dihydrofolate reductase]] | [[Category: Dihydrofolate reductase]] | ||
[[Category: Staphylococcus aureus]] | [[Category: Staphylococcus aureus]] | ||
Revision as of 11:18, 26 July 2012
Contents |
Staphylococcus aureus F98Y DHFR complexed with iclaprim
Template:ABSTRACT PUBMED 19211577
About this Structure
3fra is a 1 chain structure of Dihydrofolate reductase with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
See Also
Reference
- Oefner C, Bandera M, Haldimann A, Laue H, Schulz H, Mukhija S, Parisi S, Weiss L, Lociuro S, Dale GE. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity. J Antimicrob Chemother. 2009 Apr;63(4):687-98. Epub 2009 Feb 11. PMID:19211577 doi:10.1093/jac/dkp024
